Peru

Last Updated 5 March 2021.

2 Vaccines Approved for Use in Peru

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  12 trials in 9 countries

  RNA

• Sinopharm (Beijing)
  BBIBP-CorV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 19 countries

  6 trials in 7 countries

  Inactivated

5 Vaccines in Clinical Trials in Peru

• Curevac
  CVnCoV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  5 trials in 4 countries

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 other countries

  8 trials in 17 countries

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 other countries

  22 trials in 13 countries

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  BBIBP-CorV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 19 countries

  6 trials in 7 countries

  Inactivated

• Sinopharm (Wuhan)
  Inactivated (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 other countries

  6 trials in 7 countries

  Inactivated